Philippe Bey

Dr. Bey has participated in and led teams responsible for over 30 INDs in many therapeutic areas, including oncology, respiratory diseases, infectious diseases, inflammation, metabolic and central nervous system diseases. He was previously Senior VP of R&D at Thraso Therapeutics. Prior to joining Thrasos, Dr. Bey was the Chief Scientific Officer and Senior Vice President of R&D at ArQule and also served as U.S. Senior Vice President of R&D at Hoechst Marion Roussel (HMR), now Sanofi Aventis. He also served at HMR’s parent companies, Marion Merrell Dow, Merrell Dow and Richardson Merrell, in numerous scientific and management leadership positions, both in Europe and in the U.S. Dr. Bey received his Ph.D. and B.S. in chemistry from the University Louis Pasteur in Strasbourg, France and did his post-doctoral training at the California Institute of Technology. He has also served as an adjunct professor of medicinal chemistry at the University Louis Pasteur. Dr. Bey has authored 89 publications and 20 book chapters, and holds 63 issued patents.